Covid-19. In the US, Pfizer desires to authorize its vaccine towards Omicron for 5-11 12 months olds

Pfizer and BioNTech requested US well being authorities on Monday, September 26, 2022 to authorize their anti-Covid vaccine for youngsters aged 5 to 11 particularly concentrating on the Omicron variant, the 2 teams introduced in a press launch.

The request for emergency authorization has been despatched to the US Drug Administration (FDA) for a booster dose of 10 micrograms.

Within the occasion of a optimistic response from the FDA, the Facilities for Illness Prevention and Management (CDC), the nation’s foremost federal well being company, will in flip should challenge their suggestions earlier than the primary injections are administered to kids.

A request for authorization for Europe

An analogous request for authorization shall be despatched within the coming days to the European Medicines Company (EMA) specifies the press launch.

The brand new technology of anti-Covid vaccine, known as bivalent, targets each the unique pressure of the coronavirus, and the BA.4 and BA.5 lineages of the Omicron variant. They at present symbolize greater than 90% of contamination in the US.

Whereas kids have been much less affected by Covid-19 than adults, a number of hundred of them aged 5 to 18 have died in the US because the begin of the pandemic, in response to CDC figures.

By the top of August, the FDA had cleared variations of the Pfizer/BioNTech and Moderna vaccines concentrating on Omicron, and the CDC subsequently really helpful them, paving the way in which for a brand new recall marketing campaign.

However solely individuals over the age of 12 for the Pfizer/BioNTech vaccine and over 18 for the Moderna vaccine are at present approved to obtain this particular booster dose.